Merck Kgaa ADR (MKKGY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MKKGY | SMMT | NBIX | ||
| Company | Merck Kgaa ADR | Summit Therapeu ADR | Neurocrine Bioscienc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 27.4590 | 24.50 | 132.89 | ||
| High | 27.7800 | 25.44 | 134.11 | ||
| Low | 27.4500 | 23.74 | 130.33 | ||
| Latest | 27.6700 | 25.12 | 131.59 | ||
| Change | -0.1325 | -0.03 | -1.66 | ||
| % Change | -0.48% | -0.12% | -1.25% | ||
| Volume | 104,700 | 3,371,400 | 1,775,700 | ||
| 20-Day Average Volume | 161,565 | 3,046,070 | 1,141,725 | ||
| Previous Close | 27.8025 | 25.15 | 133.25 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 25.7246 | 19.48 | 130.51 | ||
| 20-Day Raw Stochastic | 86.02% | 96.44% | 71.29% | ||
| 20-Day Relative Strength | 56.60 | 77.13 | 50.55 | ||
| Weighted Alpha | +1.89 | +36.28 | +13.46 | ||
| Today's Opinion | 8% Buy | 24% Buy | 72% Sell | ||
| Previous Opinion | 8% Buy | 24% Buy | 72% Sell | ||
| Last Month's Opinion | 24% Sell | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.44% since 04/13/26 | +25.41% since 04/13/26 | +4.17% since 04/13/26 | ||
| Low | 26.7930 on 04/16/26 | 20.10 on 04/14/26 | 126.32 on 04/14/26 | ||
| High | 28.3100 on 04/17/26 | 25.48 on 04/17/26 | 134.11 on 04/20/26 | ||
| 1-Month | |||||
| %Chg | +16.19% since 03/20/26 | +61.96% since 03/20/26 | +3.06% since 03/20/26 | ||
| Low | 23.7330 on 03/24/26 | 15.36 on 03/24/26 | 125.11 on 03/24/26 | ||
| High | 28.3100 on 04/17/26 | 25.48 on 04/17/26 | 134.20 on 04/07/26 | ||
| 3-Month | |||||
| %Chg | -5.92% since 01/20/26 | +56.41% since 01/20/26 | -2.19% since 01/20/26 | ||
| Low | 23.7330 on 03/24/26 | 13.83 on 02/05/26 | 122.14 on 02/12/26 | ||
| High | 30.9600 on 01/27/26 | 25.48 on 04/17/26 | 142.82 on 02/10/26 | ||
| 6-Month | |||||
| %Chg | +4.89% since 10/20/25 | +25.38% since 10/20/25 | -6.89% since 10/20/25 | ||
| Low | 23.7330 on 03/24/26 | 13.83 on 02/05/26 | 122.14 on 02/12/26 | ||
| High | 31.0000 on 01/12/26 | 25.48 on 04/17/26 | 160.18 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 17,966,282 | 19,516,828 | 13,402,551 | ||
| Shares Outstanding, K | 646,211 | 776,017 | 100,582 | ||
| Annual Sales | 23,874,800,000 | 0 | 2,860,500,000 | ||
| Annual Net Income | 2,950,690,000 | -1,079,590,000 | 478,600,000 | ||
| Last Quarter Sales | 6,130,640,000 | 0 | 805,500,000 | ||
| Last Quarter Net Income | 381,870,000 | -219,170,000 | 153,700,000 | ||
| 60-Month Beta | 1.02 | -1.36 | 0.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.28 on 03/05/26 | -0.29 on 02/23/26 | 1.88 on 02/11/26 | ||
| Latest Earnings Date | 05/21/26 | 05/07/26 | 05/05/26 | ||
| Most Recent Dividend | 0.338 on 04/29/25 | N/A | N/A | ||
| Next Ex-Dividends Date | 04/28/26 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 12.00 | 0.00 | 27.85 | ||